Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-25-001811
Filing Date
2025-08-14
Accepted
2025-08-14 16:08:04
Documents
56
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20250630x10q.htm   iXBRL 10-Q 1480264
2 EX-10.1 tmb-20250630xex10d1.htm EX-10.1 93453
3 EX-31.1 tmb-20250630xex31d1.htm EX-31.1 12986
4 EX-31.2 tmb-20250630xex31d2.htm EX-31.2 12879
5 EX-32 tmb-20250630xex32.htm EX-32 9833
  Complete submission text file 0001410578-25-001811.txt   6055261

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20250630.xsd EX-101.SCH 49185
7 EX-101.CAL tmb-20250630_cal.xml EX-101.CAL 53562
8 EX-101.DEF tmb-20250630_def.xml EX-101.DEF 231212
9 EX-101.LAB tmb-20250630_lab.xml EX-101.LAB 437551
10 EX-101.PRE tmb-20250630_pre.xml EX-101.PRE 318580
59 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20250630x10q_htm.xml XML 807932
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

EIN.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39752 | Film No.: 251218941
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)